Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ASP2151 on Bupropion PK in Healthy Men
NCT02369172Phase 1Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Feb 2015
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Amenamevir in herpes zoster (HZ), sponsored by Maruho Co., Ltd. Primary endpoints: Peak Plasma Concentration of Bupropion at Day 29 and Area Under the Concentration-time Curve Extrapolated to Infinite Time of Bupropion at Day 29. Started Feb 2015; status: completed.
02
Drugs
Amenamevir
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02369172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02369172.